Navigation Links
PharmaPoint: Alzheimer’s Disease - US Drug Forecast and Market Analysis to 2022
Date:10/21/2013

apy 69
6.1.7 Behavioral Treatments 70
6.2 Gap Analysis 70
6.2.1 Disease Prevention 71
6.2.2 Diagnosis from Biomarkers 72
6.2.3 Behavioral Therapies 73
7 Pipeline Assessment 74
7.1 Overview 74
7.2 Early-Stage Pipeline Assessment 74
7.3 AD Pipeline by Mechanism of Action 77
7.4 Enzymatic Processing 77
7.5 Immunization 78
7.6 Anti-Aggregation 79
7.7 “Me-Too” 79
7.8 Novel Therapeutic Approaches 80
7.9 Technology Trends Analytic Framework 81
7.10 Promising Drugs in Clinical Development 82
7.10.1 Namenda XR 83
7.10.2 Arimenda 86
7.10.3 Gammagard Liquid 10% 89
7.10.4 Solanezumab 91
7.10.5 Gantenerumab 95
7.10.6 Crenezumab 100
7.10.7 TRx0237 103
7.10.8 MK-8931 107
7.10.9 EVP-6124 110
7.10.10 Lu AE58054 113
8 Market Outlook 117
8.1 United States 117
8.1.1 Forecast 117
8.1.2 Key Events 121
8.1.3 Drivers and Barriers 121
9 Appendix 125
9.1 Bibliography 125
9.2 Abbreviations 140
9.3 Methodology 147
9.4 Forecasting Methodology 147
9.4.1 Diagnosed AD patients 148
9.4.2 Percent Drug-treated Patients 148
9.4.3 Drugs Included in Each Therapeutic Class 149
9.4.4 Launch and Patent Expiry Dates 149
9.4.5 General Pricing Assumptions 150
9.4.6 Individual Drug Assumptions 150
9.4.7 Generic Erosion 156
9.4.8 Pricing of Pipeline Agents 156
9.5 Physicians and Specialists Included in this Study 158
9.6 About the Authors 159
9.6.1 Author 159
9.6.2 Global Head of Healthcare 160
9.7 About GlobalData 161
9.8 Disclaimer 161

List of Tables

Table 1:Symptoms of AD 32
Table 2:Guidelines for the Treatment of AD 39
Table 3:Most Prescribed Drugs for AD by Class in the Global Markets, 2012 40
Table 4:Leading Branded Treatment
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics - US Drug Forecast and Market Analysis to 2022
2. PharmaPoint: Chronic Myeloid Leukemia (CML) - United States Drug Forecast and Market Analysis to 2022
3. PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics - Current and Future Players
4. PharmaPoint: Chronic Myeloid Leukemia (CML) - United Kingdom Drug Forecast and Market Analysis to 2022
5. The Alzheimer’s Caregiver™ Offers a New Educational Concept of Care That Bridges the Gap between Research and Caregiving
6. The Alzheimer’s Caregiver™ - Bridges the Gap between Research and Care
7. National League for Nursing to Create Alzheimer’s Curricula and Resources for Nurse Educators
8. Physicians Group Calls on the FDA to Repurpose Enbrel for the Treatment of TBI, Stroke and Alzheimer’s Disease
9. The Alzheimer’s Epidemic Is Coming. How Can The National Association of Professional Geriatric Care Managers Help Prepare Families?
10. WOW Memories Announces New Efforts to Help Support Alzheimer’s Charity Events
11. Minocycline Enhances the Efficacy of Perispinal Enbrel in Traumatic Brain Injury Treatment as well as Stroke Treatment and Alzheimer’s Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... ... 28, 2015 , ... For Dallas, the time is nearing for the annual ... Tenet Health. , The American Heart Association hosts their well-known Heart Walk to raise ... together, a difference can be made. Walkers can participate in the cause and someone ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... As ... from Merz, received FDA clearance for results that last for two years, the ... exciting news for patients who are looking for a long-lasting, effective solution for their ...
(Date:8/28/2015)... , ... August 28, 2015 , ... On May 30th, ... joined as sponsor of the “Music With A Mission” benefit concert in Mendon, IL. ... event was to raise money to support music education programs in the underfunded local ...
(Date:8/28/2015)... ... August 28, 2015 , ... Saint Petersburg, FL ... with zero fat, carbs, sugar, gluten, lactose or caffeine in a convenient 2 ... 2015 SupplySide CPG Editor’s Choice Awards. , Five consumer packaged goods (CPG) products ...
(Date:8/28/2015)... ... August 28, 2015 , ... Altima Technologies, Inc., the ... and data center assets and audio-video devices, recently released Visio Stencils for the ... HP ProLiant Gen9, EMC VNX Series , Super Micro Computer SuperStorage, Hitachi Data ...
Breaking Medicine News(10 mins):Health News:North Central Surgical Center’s Subsidiary Participates in Walk 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 3Health News:New Video Released on "Music With A Mission" Benefit Concert Headlining Artist Cadillac Three & Best Drug Rehabilitation 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 2Health News:Altima Updates NetZoom™ Visio® Stencil Library for Cisco, HP, and EMC Devices 3
... , , BOTHELL, Wash., Sept. ... ) announced today that on September 15, 2009, the NYSE ... with respect to its previously disclosed listing deficiency as set ... Such deficiency relates to the Company,s failure to maintain stockholder,s ...
... SOMERSET, N.J., Sept. 18 TeamStaff, Inc. ... healthcare and administrative staffing services, today announced that on September ... Department of The Nasdaq Global Market (Nasdaq) stating that for ... has not maintained a minimum market value of publicly held ...
... , CHICAGO, Sept. 18 As economic, ... in Illinois, the state,s leading provider of addiction treatment services ... people who can,t afford expensive clinics but also fail to ... Gateway Foundation Inc., a 41-year-old non-profit organization, serves more than ...
... stems from access to alcohol or feelings of isolation remains ... study suggests there,s a link between suicide and rural communities ... research doesn,t confirm that more bars mean more suicides because ... those who commit suicide, about 20 percent are alcoholics, according ...
... SAN FRANCISCO, Sept. 18 VIA Pharmaceuticals, Inc. ... the development of compounds for the treatment of cardiovascular and ... received a deficiency letter from the NASDAQ Stock Market stating ... $1.00 per share bid price requirement for continued listing, as ...
... , , BROOMFIELD, Colo., Sept. 18 Accera, ... diseases, today announced today that it will present at the UBS ... , , Steve Orndorff, Ph.D., founder, president and ... on Axona (TM) on Monday, September 21 at 11:30 a.m. ...
Cached Medicine News:Health News:SCOLR Pharma, Inc. Receives Notice from NYSE Amex LLC Regarding Compliance Plan and Listing Standards 2Health News:SCOLR Pharma, Inc. Receives Notice from NYSE Amex LLC Regarding Compliance Plan and Listing Standards 3Health News:SCOLR Pharma, Inc. Receives Notice from NYSE Amex LLC Regarding Compliance Plan and Listing Standards 4Health News:TeamStaff Receives Nasdaq Deficiency Notice Related to the Market Value of Its Publicly Held Shares 2Health News:TeamStaff Receives Nasdaq Deficiency Notice Related to the Market Value of Its Publicly Held Shares 3Health News:Gateway Responding To Increased Need for Treatment Among Middle-Income Substance Abusers 2Health News:Suicides Higher in Rural Areas With Bars 2Health News:VIA Pharmaceuticals Receives Anticipated Deficiency Notice From NASDAQ 2Health News:VIA Pharmaceuticals Receives Anticipated Deficiency Notice From NASDAQ 3Health News:VIA Pharmaceuticals Receives Anticipated Deficiency Notice From NASDAQ 4Health News:Accera, Inc. to Present at UBS Global Life Sciences Conference 2
(Date:8/28/2015)... , Aug. 28, 2015 ... the addition of the "Investigation Report on China,s ... Tobramycin is a traditional antibiotic whose eye drop ... the treatment of potential infection or inflammation caused by ... China are able to produce tobramycin, among ...
(Date:8/28/2015)... Aug. 28, 2015 ... addition of the "Investigation Report on China,s ... offering. Developed by Novo Nordisk, insulin ... an important drug for the treatment of diabetes. ... fast- acting insulin analog, starts working fast and ...
(Date:8/28/2015)... -- IP Shakti, LLC, today announced that it has changed its ... Logo - http://photos.prnewswire.com/prnh/20150827/261551LOGO ... signifies our transformation into a company focused on patent claim ... claim validity." ... platform, the Company commenced a corporate re-branding initiative in order ...
Breaking Medicine Technology:Investigation Report on China's Tobramycin Market, 2015-2019 2China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2IP Shakti, LLC Changes Company Name to Prediqtus, LLC 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: